GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioNote Inc (XKRX:377740) » Definitions » Equity-to-Asset

BioNote (XKRX:377740) Equity-to-Asset : 0.96 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BioNote Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BioNote's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩1,567,809 Mil. BioNote's Total Assets for the quarter that ended in Mar. 2024 was ₩1,630,927 Mil. Therefore, BioNote's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.96.

The historical rank and industry rank for BioNote's Equity-to-Asset or its related term are showing as below:

XKRX:377740' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.75   Med: 0.88   Max: 0.98
Current: 0.96

During the past 5 years, the highest Equity to Asset Ratio of BioNote was 0.98. The lowest was 0.75. And the median was 0.88.

XKRX:377740's Equity-to-Asset is ranked better than
98.73% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs XKRX:377740: 0.96

BioNote Equity-to-Asset Historical Data

The historical data trend for BioNote's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNote Equity-to-Asset Chart

BioNote Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
0.85 0.75 0.86 0.91 0.98

BioNote Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.93 0.93 0.98 0.96

Competitive Comparison of BioNote's Equity-to-Asset

For the Medical Devices subindustry, BioNote's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNote's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioNote's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where BioNote's Equity-to-Asset falls into.



BioNote Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

BioNote's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1556575.913/1592842.324
=0.98

BioNote's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=1567808.979/1630927.458
=0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNote  (XKRX:377740) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


BioNote Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of BioNote's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNote (XKRX:377740) Business Description

Traded in Other Exchanges
N/A
Address
22, Samsung 1-ro 4-gil, Gyeonggi-do, Hwaseong-si, KOR
BioNote Inc is a manufacturer of diagnostic kits and equipment for animal diseases and is equipped with a wide product portfolio, from initial screening tests to molecular diagnosis. Its animal diagnostics products comprise of Vcheck F, Vcheck M, Vcheck C, Rapid, and ELISA.

BioNote (XKRX:377740) Headlines

No Headlines